MS-8209, a new amphotericin B derivative, provides enhanced efficacy in delaying hamster scrapie.
To test the efficacy of a new amphotericin B derivative, MS-8209, in delaying scrapie, hamsters were infected intracerebrally with the 263K scrapie agent and treated with MS-8209 either early in the course of the disease or continuously. The results show that (i) all treatments lengthened the incuba...
Guardat en:
| Publicat a: | Antimicrob Agents Chemother |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Microbiology (ASM)
1995
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC163037/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8593027/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.39.12.2810 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|